Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 19/20 | 0.49 |
| ▸ | ITGAV | P06756 | 19/20 | 0.49 |
| ▸ | ITGB6 | P18564 | 13/20 | 0.46 |
| ▸ | ITGB5 | P18084 | 13/20 | 0.46 |
| ▸ | ITGB8 | P26012 | 12/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20156301 | 0.93 | ITGB3 (0.57) | ITGB3ITGAVITGB6ITGB5ITGB8 | |
| SCHEMBL20156083 | 0.87 | ITGB3 (0.40) | ITGB3ITGAVITGB6ITGB5ITGB8 | |
| SCHEMBL23912902 | 0.86 | ITGB3 (0.53) | ITGB3ITGAVITGB6ITGB5ITGB8 | |
| SCHEMBL23912908 | 0.85 | NPC1 (0.34) | ITGB3ITGAV | |
| SCHEMBL23912864 | 0.84 | ITGB3 (0.60) | ITGB3ITGAVITGB6ITGB5ITGB8 | |
| SCHEMBL20156034 | 0.84 | ITGAV (0.49) | ITGB3ITGAVITGB6ITGB5ITGB8 | |
| SCHEMBL20156291 | 0.84 | ITGB3 (0.62) | ITGB3ITGAVITGB6ITGB5ITGB8 | |
| SCHEMBL20156282 | 0.81 | ITGB3 (0.57) | ITGB3ITGAVITGB6ITGB5ITGB8 | |
| SCHEMBL20156250 | 0.80 | ITGAV (0.52) | ITGB3ITGAVITGB6ITGB5ITGB8 | |
| SCHEMBL20156082 | 0.79 | ITGB3 (0.49) | ITGB3ITGAVITGB6ITGB5ITGB8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538527-B1 | AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2021-10-13 | — | — | EP | disclosed |
| WO-2018089358-A1 | AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-05-17 | — | — | WO | disclosed |